Nykode Therapeutics AS (OSL:NYKD)
Norway
· Delayed Price · Currency is NOK 3.120
-0.046 (-1.45%)
At close: Mar 9, 2026
Nykode Therapeutics AS Ratios and Metrics
Market cap in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,034 | 788 | 995 | 6,988 | 8,287 | 23,372 | Upgrade
|
| Market Cap Growth | 26.14% | -20.81% | -85.77% | -15.67% | -64.54% | 9.44% | Upgrade
|
| Enterprise Value | 452 | 178 | -270 | 5,353 | 6,040 | 21,724 | Upgrade
|
| Last Close Price | 3.17 | 2.41 | 1.99 | 13.98 | 18.37 | 52.72 | Upgrade
|
| Forward PE | - | - | - | - | 4.32 | 4.32 | Upgrade
|
| PS Ratio | 226.40 | 172.48 | 9.56 | 51.73 | 93.16 | 74.18 | Upgrade
|
| PB Ratio | 1.12 | 0.85 | 0.64 | 4.02 | 5.36 | 13.67 | Upgrade
|
| P/TBV Ratio | 1.12 | 0.85 | 0.64 | 4.03 | 5.36 | 13.67 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 9341.31 | Upgrade
|
| P/OCF Ratio | - | - | - | - | - | 2296.91 | Upgrade
|
| EV/Sales Ratio | 98.94 | 38.99 | - | 39.62 | 67.90 | 68.94 | Upgrade
|
| EV/FCF Ratio | -1.52 | - | - | - | - | 8682.61 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 25.25 | Upgrade
|
| Net Debt / Equity Ratio | -0.63 | -0.63 | -0.82 | -0.92 | -1.28 | -1.14 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.07 | 2.07 | 2.35 | 2.73 | 3.81 | 20.70 | Upgrade
|
| Net Debt / FCF Ratio | 1.96 | 1.96 | 2.18 | 1.59 | 8.60 | -778.98 | Upgrade
|
| Asset Turnover | 0.00 | 0.00 | 0.05 | 0.06 | 0.04 | 0.14 | Upgrade
|
| Quick Ratio | 9.99 | 9.99 | 12.78 | 7.94 | 5.41 | 8.12 | Upgrade
|
| Current Ratio | 9.99 | 9.99 | 12.87 | 8.04 | 5.44 | 8.16 | Upgrade
|
| Return on Equity (ROE) | -10.75% | -10.75% | -25.25% | -21.42% | -24.35% | -5.05% | Upgrade
|
| Return on Assets (ROA) | -14.10% | -14.10% | -16.70% | -16.90% | -13.64% | -2.72% | Upgrade
|
| Return on Invested Capital (ROIC) | -79.39% | -98.49% | -250.18% | - | - | - | Upgrade
|
| Return on Capital Employed (ROCE) | -30.50% | -30.50% | -33.50% | -31.00% | -29.10% | -4.60% | Upgrade
|
| Earnings Yield | -11.93% | -15.67% | -44.34% | -5.10% | -5.08% | -0.36% | Upgrade
|
| FCF Yield | -28.76% | -37.75% | -58.58% | -14.30% | -2.78% | 0.01% | Upgrade
|
| Dividend Yield | 31.59% | - | 50.26% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | 6.29% | 6.29% | -8.66% | -3.58% | -1.32% | 3.31% | Upgrade
|
| Total Shareholder Return | 37.88% | 6.29% | 41.60% | -3.58% | -1.32% | 3.31% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.